{"id":"https://openalex.org/W7204698190","doi":"https://doi.org/10.2174/0115734064503567260817161010","title":"Pyrimidine Derivatives as Anticancer Agents: Structural Insights and SAR Studies","display_name":"Pyrimidine Derivatives as Anticancer Agents: Structural Insights and SAR Studies","publication_year":2026,"publication_date":"2026-08-25","ids":{"openalex":"https://openalex.org/W7204698190","doi":"https://doi.org/10.2174/0115734064503567260817161010","pmid":"https://pubmed.ncbi.nlm.nih.gov/42695322"},"language":"en","primary_location":{"id":"doi:10.2174/0115734064503567260817161010","doi":"https://doi.org/10.2174/0115734064503567260817161010","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0115734064503567260817161010","pdf_url":null,"source":{"id":"https://openalex.org/S155723790","display_name":"Medicinal Chemistry","issn_l":"1573-4064","issn":["1573-4064","1875-6638"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102868017","display_name":"Balasubramanian Narasimhan","orcid":"https://orcid.org/0000-0002-9627-094X","observed_orcids":["https://orcid.org/0000-0002-9627-094X"]},"institutions":[{"id":"https://openalex.org/I905734797","display_name":"Maharshi Dayanand University","ror":"https://ror.org/03kaab451","country_code":"IN","type":"education","lineage":["https://openalex.org/I905734797"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Balasubramanian Narasimhan","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak124001, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak124001, India","institution_ids":["https://openalex.org/I905734797"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074029344","display_name":"Ashu Sapra","orcid":"https://orcid.org/0000-0002-1140-775X","observed_orcids":["https://orcid.org/0000-0002-1140-775X"]},"institutions":[{"id":"https://openalex.org/I905734797","display_name":"Maharshi Dayanand University","ror":"https://ror.org/03kaab451","country_code":"IN","type":"education","lineage":["https://openalex.org/I905734797"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashu Sapra","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak124001, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak124001, India","institution_ids":["https://openalex.org/I905734797"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I905734797"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.59728341,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.8428000211715698,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.8428000211715698,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.1388999968767166,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyrimidine-derivatives","display_name":"pyrimidine derivatives","score":1.0},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9850000143051147},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8759999871253967},{"id":"https://openalex.org/keywords/fused-pyrimidines","display_name":"fused pyrimidines","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pyrazolo-3-4-d-pyrimidines","display_name":"pyrazolo[3,4-d]pyrimidines","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pyrido-2-3-d-pyrimidines","display_name":"pyrido[2,3-d]pyrimidines","score":0.9779999852180481},{"id":"https://openalex.org/keywords/quinazolines","display_name":"quinazolines","score":0.9869999885559082},{"id":"https://openalex.org/keywords/furo-2-3-d-pyrimidines","display_name":"furo[2,3-d]pyrimidines","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8140000104904175},{"id":"https://openalex.org/keywords/target-based-drug-discovery","display_name":"target-based drug discovery","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.9258000254631042},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47760000824928284},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4293000102043152},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.42480000853538513},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4066999852657318},{"id":"https://openalex.org/C13576564","wikidata":"https://www.wikidata.org/wiki/Q6594591","display_name":"Pyrimidine analogue","level":3,"score":0.4016999900341034},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.3831999897956848},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32710000872612},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.3107999861240387},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.304500013589859},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2840000092983246},{"id":"https://openalex.org/C200159599","wikidata":"https://www.wikidata.org/wiki/Q4893563","display_name":"Pyrimidine metabolism","level":4,"score":0.27970001101493835},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2754000127315521},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26499998569488525},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2574000060558319},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.25360000133514404}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2174/0115734064503567260817161010","doi":"https://doi.org/10.2174/0115734064503567260817161010","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0115734064503567260817161010","pdf_url":null,"source":{"id":"https://openalex.org/S155723790","display_name":"Medicinal Chemistry","issn_l":"1573-4064","issn":["1573-4064","1875-6638"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:42695322","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42695322","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal chemistry (Shariqah (United Arab Emirates))","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"The":[0,56,116,256],"structural":[1,27,230],"variety":[2,83],"and":[3,26,53,59,69,107,163,176,195,250],"associated":[4],"biological":[5,21,85],"potential":[6,86],"of":[7,23,29,47,77,84,98,118,129,222,259,269],"pyrimidine":[8,57,109,171,206,224,245,270],"derivatives":[9,25,28,42,246,271],"have":[10,33,43,72,111,247],"made":[11],"them":[12],"attractive":[13],"to":[14,18,36,80,136,182,234,263],"medicinal":[15],"chemists.":[16],"Due":[17],"the":[19,81,127,214,219,229,239,265,277],"various":[20,170,223],"activities":[22],"Pyrimidine":[24,41],"DNA,":[30],"many":[31],"researchers":[32,143,201],"been":[34,248],"prompted":[35],"explore":[37,169],"this":[38,141,166,260],"area.":[39],"Substituted":[40],"a":[44,74,101,134,152],"broad":[45],"range":[46],"pharmacological":[48],"applications,":[49],"including":[50,105],"antimicrobial,":[51],"anticancer,":[52],"anti-inflammatory":[54],"activities.":[55,255],"ring":[58],"its":[60],"fused":[61,92,108],"derivatives,":[62,110,172,225],"which":[63],"include":[64],"pyrazolo[3,4-d]pyrimidine,":[65],"pyrido[2,3-":[66],"d]pyrimidine,":[67],"quinazoline,":[68],"furo[2,3-d]":[70],"pyrimidine,":[71],"generated":[73],"great":[75],"deal":[76],"attention":[78],"due":[79],"high":[82],"that":[87,232],"they":[88],"possess.":[89],"In":[90,238],"addition,":[91],"pyrimidines":[93,106],"are":[94,144],"intended":[95],"as":[96,151,273],"bioisosteres":[97],"purines.":[99],"As":[100],"result,":[102],"numerous":[103,130,243],"substances,":[104],"demonstrated":[112],"promising":[113,153],"anticancer":[114,131,158,236,254,274],"potential.":[115],"emergence":[117],"multidrug":[119],"resistance":[120],"in":[121,192],"cancer":[122,137,193],"cells":[123],"has":[124],"significantly":[125],"reduced":[126],"effectiveness":[128],"drugs,":[132],"posing":[133],"challenge":[135],"treatment.":[138],"To":[139],"avoid":[140],"issue,":[142],"continuously":[145],"focusing":[146],"on":[147],"target-based":[148],"drug":[149],"discovery":[150],"pathway":[154],"for":[155,252],"developing":[156],"novel":[157,244],"agents":[159,275],"with":[160,178,188,209],"improved":[161],"efficacy":[162],"selectivity.":[164,212],"Specifically,":[165],"review":[167,215,261],"will":[168,216],"examining":[173],"positional":[174],"substitutions":[175],"fusion":[177],"other":[179],"heterocyclic":[180],"rings":[181],"elucidate":[183],"how":[184],"these":[185,199],"compounds":[186],"interact":[187],"molecular":[189],"targets":[190],"involved":[191],"development":[194],"progression.":[196],"By":[197],"understanding":[198],"interactions,":[200],"can":[202],"design":[203],"more":[204],"potent":[205],"-based":[207],"drugs":[208],"better":[210],"target":[211],"Moreover,":[213],"also":[217],"explain":[218],"structure-activity":[220],"relationships":[221],"providing":[226],"insights":[227],"into":[228],"features":[231],"contribute":[233],"their":[235,253],"activity.":[237],"past":[240,278],"few":[241],"years,":[242],"developed":[249,272],"studied":[251],"primary":[257],"objective":[258],"is":[262],"evaluate":[264],"structureactivity":[266],"relationship":[267],"(SAR)":[268],"over":[276],"decade.":[279]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2026-08-31T00:00:00"}